discuss $4 billion pipeline sale to Global Infrastructure Partners +0.42%) +1.6%) Astrazeneca speculation that they have made a 1st round bid for Amylin (trading Roche's Actemra beats Abbott's Humira in Rheumatoid arthritis trials (trading Sports Direct eyeing up Umbro bid according to the Sunday Ti

06 9705.06 0 705.06 0 705.06 0 0 0 705.06 L HBFT Highbridge - Financial Trust Co. CREDIT-SUISSE 0 - Financial BOND BOND AMLN 2.5_4/11 Amylin Pharm 2.5% 4/15/2011 -540230 540230 8/29/2005 12588752 BUY 1 156,665 156,665 - 156,665 13112671 SEL 1 USD US DOLLAR CSFB 696895 156665 0

006 to 3/31/2006 CURRENCY: BROKER: US DOLLAR CREDIT-SUISSE FIRST BOSTON Qty Trx. Num Trade Date SECURITY TYPE: BOND SECURITY AMLN_2.5_4/11 - Amylin Pharm 2.5% 4/15/2011 144a -500 12588752 -500 12599520 -1,000 12499158 -8 12499171 -17 12411068 -10 12411072 -15 12357536 06/29/05 BUY 06

SHT 01/11/06 SHT 02/22/06 SHT Opening Transaction Local Proceeds FX Rate 71,987.49 86,947.83 40,624.02 858,961.76 SECURITY AMLN_2.5_4/11 - Amylin Pharm 2.5% 4/15/2011 144a -500 -540,230.00 -544,770.00 -1,085,000.00 8,702.90 1,514.78 10,217.68 SECURITY B_3.75_8/25_144A - BARNES GROUP INC